Enantioselective binding analysis of verapamil to plasma lipoproteins by capillary electrophoresis-frontal analysis

Journal of Chromatography A

Volumn 875, Issue 1-2, 2000, Pages 447-453

  Mohamed, Niveen Abdel Latif ^a   Kuroda, Yukihiro ^a   Shibukawa, Akimasa ^a   Nakagawa, Terumichi ^a   El Gizawy, Samia ^b   Askal, Hassan F ^b   El Kommos, Micheal E ^b  

^a KYOTO UNIVERSITY   (Japan)

^b Assiut University   (Egypt)

Author keywords

Binding studies; Enantiomer separation; Frontal analysis; Lipoproteins; Proteins; Verapamil

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; COPPER ION; LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; VERAPAMIL;

ARTICLE; BINDING AFFINITY; CALIBRATION; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; ENANTIOMER; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; TECHNIQUE; ULTRACENTRIFUGATION;

ELECTROPHORESIS, CAPILLARY; HUMANS; LIPOPROTEINS; MALE; STEREOISOMERISM; VERAPAMIL;

EID: 0034646953     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9673(99)01288-1     Document Type: Article

References (36)

1. Meyer M.C., Guttman D.E. J. Pharm. Sci. 57:1968;895.
2. Vallner J.J. J. Pharm. Sci. 66:1977;447.
3. Kwong T.C. Clin. Chem. Acta. 151:1985;193.
4. Tucker G.T., Lennard M.S. Pharmacol. Ther. 45:1989;309.
5. Noctor T. Wainer I.W. Drug Stereochemistry. 2nd ed. 1993;Marcel Dekker, New York. Chapter 12.
6. Urien S. Tillement J.P., Lindenlaub E. Protein Binding and Drug Transport. 1986;63-75 F.K. Schattauer Verlag, Stuttgart, New York.
7. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. New Engl. J. Med. 320:1989;915.
8. Witztum J.L., Steinberg D. J. Clin. Invest. 88:1991;1785.
9. Quinn M.T., Parthasarathy S., Fong L.G., Steinberg D. Proc. Natl. Acad. Sci. 84:1987;2995.
10. Quinn M.T., Parthasarathy S., Steinberg D. Proc. Natl. Acad. Sci. 82:1985;5949.
11. Lloyd D.K., Li S., Ryan P. J. Chromatogr. A. 694:1995;285.
12. Tanaka Y., Terabe S. J. Chromatogr. A. 694:1995;277-284.
13. Tanaka Y., Terabe S. Chromatographia. 44:1997;119-126.
14. Haginaka J., Kanasugi N. J. Chromatogr. A. 782:1997;281-288.
15. Oravcova J., Boehs B., Lindner W. J. Chromatogr. B. 677:1996;1.
16. Hage D.S., Tweed S.A. J. Chromatogr. B. 699:1997;499.
17. Shibukawa A., Yoshimoto Y., Ohara T., Nakagawa T. J. Pharm. Sci. 83:1994;616.
18. Ohara T., Shibukawa A., Nakagawa T. Anal. Chem. 67:1995;3520.
19. Shiono H., Shibukawa A., Kuroda Y., Nakagawa T. Chirality. 9:1997;291.
20. Kuroda Y., Shibukawa A., Nakagawa T. Anal. Biochem. 268:1999;9.
21. Echizen H., Manz M., Eichelbaum M. J. Cardiovasc. Pharmacol. 12:1988;543.
22. Dushkin M.I., Schwarz Y.S. Biochem. Pharmacol. 49:1995;389.
23. Rojstaczer N., Triggle D.J. Biochem. Pharmacol. 51:1996;141.
24. Karmansky I., Fruener N. Clin. Chem. Acta. 259:1997;177.
25. Hatch F.T., Lees R.S. Adv. Lipid Res. 6:1968;1.
26. Auerbach B.J., Bisgaier C.L., Wolle J., Saxena U. J. Biol. Chem. 271:1996;1329.
27. Maeba R., Shimasaki H., Ueta N. Biochim. Biophys. Acta. 1215:1994;76.
28. Markwell M.A.K., Haas S.M., Bieber L.L., Tolbert N.E. Anal. Biochem. 81:1978;206.
29. Busch M.H.A., Kraak J.C., Poppe H. J. Chromatogr. A. 777:1997;329.
30. Busch M.H.A., Carels L.B., Boelens H.F.M., Kraak J.C., Poppe H. J. Chromatogr. A. 777:1997;311.
31. Nakagawa T., Oda Y., Shibukawa A., Fukuda H., Tanaka H. Chem. Pharm. Bull. 37:1989;707.
32. Lloyd D.K., Watzig H. J. Chromatogr. B. 663:1995;400.
33. Kostner G.M., Laggner P. Fruchart J.C., Shepherd J. Human Plasma Lipoproteins. 1989;23-54 Walter de Gruyter, Berlin, New York.
34. Mahley R.W., Innerarity T.L., Rall S.C. Jr., Weisgraber K.H. J. Lipid Res. 25:1984;1277.
35. Thomas C.E., Jackson R.L. J. Pharmacol. Exp. Ther. 256:1991;1182.
36. Steinbrecher U.P. J. Biol. Chem. 262:1987;3603.